Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 2/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27679728 | 0.98 | HRH1 (0.53) | HRH1HRH3ALDH1A1NPC1RAB9A | |
| Oxalic Acid SCHEMBL28775065 | 0.89 | CYP1A2 (0.50) | HRH1HRH3ALDH1A1NPC1RAB9A | |
| SCHEMBL28723685 | 0.89 | HTT (0.51) | HRH1HRH3ALDH1A1NPC1RAB9A | |
| SCHEMBL949945 | 0.88 | HRH1 (0.55) | HRH1HRH3ALDH1A1NPC1RAB9A | |
| Oxalic Acid SCHEMBL1156072 | 0.88 | HTT (0.49) | HRH1HRH3ALDH1A1NPC1RAB9A | |
| SCHEMBL11464130 | 0.83 | HRH1 (0.59) | HRH1HRH3ALDH1A1NPC1RAB9A | |
| SCHEMBL29595035 | 0.81 | HTT (0.58) | HRH1HRH3ALDH1A1NPC1RAB9A | |
| SCHEMBL1825837 | 0.81 | HTT (0.58) | HRH1HRH3ALDH1A1NPC1RAB9A | |
| SCHEMBL5941270 | 0.80 | ALDH1A1 (0.59) | HRH1HRH3ALDH1A1NPC1RAB9A | |
| SCHEMBL8280335 | 0.80 | HRH1 (0.52) | HRH1HRH3ALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7888523-B2 | Preparation of platinum(II) complexes | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2011-02-15 | — | — | US | claimed |
| US-7589225-B2 | Preparation of platinum(II) complexes | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2009-09-15 | — | — | US | claimed |
| US-7576126-B2 | Platinum (II) complexes, preparation and use | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2009-08-18 | — | — | US | claimed |
| EP-1789427-B1 | PREPARATION OF PLATINUM(II) COMPLEXES | PLATCO TECHNOLOGIES PROPRIETAR (ZA) | 2009-05-20 | — | — | EP | claimed |
| US-20080064895-A1 | Preparation of Platinum(II) Complexes | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2008-03-13 | — | — | US | claimed |
| CN-101018797-A | Preparation of platinum (II) complexes | PLATCO TECHNOLOGIES PROPRIETAR (ZA) | 2007-08-15 | — | — | CN | claimed |
| US-20070167643-A1 | Platinum (II) complexes, preparation and use | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2007-07-19 | — | — | US | claimed |
| EP-1789427-A1 | PREPARATION OF PLATINUM(II) COMPLEXES | Platco Technologies (Proprietary) Limited (ZA) | 2007-05-30 | — | — | EP | claimed |
| EP-1704156-A1 | PLATINUM(II) COMPLEXES, PREPARATION AND USE | Platco Technologies (Proprietary) Limited (ZA) | 2006-09-27 | — | — | EP | claimed |
| WO-2006024897-A1 | PREPARATION OF PLATINUM(II) COMPLEXES | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2006-03-09 | — | — | WO | claimed |
| WO-2005051966-A1 | PLATINUM(II) COMPLEXES, PREPARATION AND USE | PLATCO TECHNOLOGIES (PROPRIETARY) LIMITED (ZA) | 2005-06-09 | — | — | WO | claimed |
| US-4038435-A | FLAVORING AGENT | FIRMENICH & CIE (CH) | 1977-07-26 | — | — | US | claimed |
| US-9895443-B2 | Multi-tailed lipids and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-02-20 | — | — | US | disclosed |
| WO-2017112777-A1 | COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE | SHY Therapeutics LLC (US) | 2017-06-29 | — | — | WO | disclosed |
| US-8329704-B2 | Substituted pyrazinone derivatives for use in MCH-1 mediated diseases | JANSSEN PHARMACEUTICA, N.V. (BE) | 2012-12-11 | — | — | US | disclosed |
| US-8329704-B2 | Substituted pyrazinone derivatives for use in MCH-1 mediated diseases | JANSSEN PHARMACEUTICA, N.V. (BE) | 2012-12-11 | — | — | US | disclosed |
| US-3952026-A | FLAVOR ADDITIVE FOR FOODS AND BEVERAGES | FIRMENICH & CIE (CH) | 1976-04-20 | — | — | US | disclosed |
| US-3943260-A | TETRAHYDRO-THIO-PHEN-3-ONES | FIRMENICH & CIE (CH) | 1976-03-09 | — | — | US | disclosed |
| US-3931245-A | FURYLALKYLTHIOL CARBOXYLATES | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
| US-3931246-A | FURYLALKYL-THIOETHERS | FIRMENICH & CIE (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070167643-A1 | Platinum (II) complexes, preparation and use | PDCD5, ORC3, PDCD2L | HRH1 3638/4885HRH3 2178/4885ALDH1A1 3930/4885 |
| US-20080064895-A1 | Preparation of Platinum(II) Complexes | SLCO4C1, SLC10A6, OTC | HRH1 3361/4885HRH3 2231/4885ALDH1A1 3885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.